FDA cites Langlinais' Baking Company in Lafayette, LA, for allergen and sanitation failures in ready-to-eat bread and rolls.
What happened
FDA inspected the ready-to-eat bakery from November 1 through 5, 2021, and issued a Form FDA-483 (the list of observations written at the end of an inspection) on November 5, 2021. Investigators found the hazard analysis did not treat undeclared allergens or allergen cross-contact as hazards needing a preventive control, and did not evaluate environmental pathogens such as Salmonella at cooling and packaging. They also saw two whole loaves of French Bread wedged between food-contact rollers and food residue on a mixer and dough forming equipment that is shared between products with and without milk. FDA notes it had received no response to the Form FDA-483, and that the firm recalled French Bread in November 2021 for undeclared wheat.
What FDA found
The hazard analysis did not consider undeclared allergens from labeling mistakes as a hazard needing a preventive control, even though the firm recalled French Bread in November 2021 for undeclared wheat.
21 CFR 117.130(a); 21 CFR 117.135(c)(2)(ii)The hazard analysis did not consider allergen cross-contact at dough mixing and forming, where equipment is shared between buns containing milk and products without milk.
21 CFR 117.130(a); 21 CFR 117.135(c)(2)(i)The hazard analysis did not evaluate environmental pathogens such as Salmonella at the cooling and packaging steps for ready-to-eat products exposed after baking.
21 CFR 117.130(c)(1)(ii); 21 CFR 117.165(a)(3)Equipment was not cleaned and sanitized in a way that protects against allergen cross-contact and contamination, with bread wedged in rollers and food residue left on a mixer and forming equipment after a cleaning was signed off as complete.
21 CFR 117.35(a)
What FDA wants
FDA tells the company to investigate the causes of the violations, correct them, and write to FDA within 15 working days of receiving the letter with the specific steps taken and documentation, or explain why more time is needed.
Who should pay attention
- retailers and distributors selling this firm's bread and rolls
- brands that buy finished baked goods from contract bakeries
- other bakeries that run allergen and non-allergen products on the same equipment
This is a summary. Read the original letter on fda.gov.